Información del producto
- CML
- (2S)-2-Amino-6-(carboxymethylamino)hexanoic acid
- <span class="text-smallcaps">L</span>-Lysine, N<sup>6</sup>-(carboxymethyl)-
- L-Lysine,N6-(carboxymethyl)-
- Lysine, N<sup>6</sup>-(carboxymethyl)-, <span class="text-smallcaps">L</span>-
- Lysine,N6-(carboxymethyl)-, L- (8CI)
- N-(3-chloro-4-fluorophenyl)-2-[(2-chlorophenyl)sulfanyl]acetamide
- N6-(1-Carboxymethyl)-L-lysine
- N6-(Carboxymethyl)lysine
- N<sup>6</sup>-(Carboxymethyl)-<span class="text-smallcaps">L</span>-lysine
- Ver más sinónimos
- N<sup>6</sup>-(Carboxymethyl)lysine
- N<sup>ε</sup>-(Carboxymethyl)lysine
- Ne-(Carboxymethyl)lysine
- e-(Carboxymethyl)lysine
- N6-(Carboxymethyl)-L-lysine
- Lysine, N6-(carboxymethyl)-, L-
Nε-(1-Carboxymethyl)-L-lysine (CML), an advanced glycation end product (AGE), is formed through the oxidative modification of glycated proteins under conditions of oxidative stress.1,2,3 Its levels escalate with age, diabetes, cancer, vascular diseases, and various pathologies associated with oxidative stress.1,4,5 CML interacts with the membrane-bound receptor for AGEs (RAGE), initiating signaling via MAPKs and NF-κB pathways. Conversely, a truncated version of RAGE generates a soluble protein that sequesters CML, thereby diminishing this signaling.6,7
Propiedades químicas
Consulta técnica sobre: TM-T84435 Nε-(1-Carboxymethyl)-L-lysine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.